LIMITED POWER OF ATTORNEY
FOR SECTION 16(a) REPORTING

	KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes,
	constitutes and appoints Friedhelm Blobel, Ph.D. and Wilson W. Cheung, and
	each of them, as the undersigneds true and lawful attorney-in-fact (the
	Attorney-in Fact), with full power of substitution and resubstitution,
	each with the power to act alone for the undersigned and in the
	undersigneds name, place and stead, in any and all capacities to:

	1.	prepare, execute, deliver and file with the United States Securities
	and Exchange Commission, any national securities exchange and SciClone
	Pharmaceuticals, Inc. (the Company) any and all reports (including any
	amendment thereto) of the undersigned required or considered advisable
	under Section 16(a) of the Securities Exchange Act of 1934, as amended
	the Exchange Act), and the rules and regulations thereunder, with respect
	to the equity securities of the Company, including Form 3 (Initial
	Statement of Beneficial Ownership of Securities), Form 4 (Statement of
	Changes in Beneficial Ownership), and Form 5 (Annual Statement of Changes
	in Beneficial Ownership); and

	2.	seek or obtain, as the undersigneds representative and on the
	undersigneds behalf, information on transactions in the Companys equity
	securities from any third party, including the Company, brokers, dealers,
	employee benefit plan administrators and trustees, and the undersigned
	hereby authorizes any such third party to release any such information to
	the Attorney-in-Fact.

	The undersigned acknowledges that:

	1.	this Limited Power of Attorney authorizes, but does not require, the
	Attorney-in-Fact to act at his or her discretion on information provided
	to such Attorney-in-Fact without independent verification of such
	information;

	2.	any documents prepared and/or executed by the Attorney-in-Fact on
	behalf of the undersigned pursuant to this Limited Power of Attorney will
	be in such form and will contain such information as the Attorney-in-Fact,
	in his or her discretion, deems necessary or desirable;

	3.	neither the Company nor the Attorney-in-Fact assumes any liability for
	the undersigneds responsibility to comply with the requirements of Section
	16 of the Exchange Act, any liability of the undersigned for any failure to
	comply with such requirements, or any liability of the undersigned for
	disgorgement of profits under Section 16(b) of the Exchange Act; and

	4.	this Limited Power of Attorney does not relieve the undersigned from
	responsibility for compliance with the undersigneds obligations under
	Section 16 of the Exchange Act, including, without, limitation, the
	reporting requirements under Section 16(a) of the Exchange Act.

	The undersigned hereby grants to the Attorney-in-Fact full power and
	authority to do and perform each and every act and thing requisite,
	necessary or convenient to be done in connection with the foregoing, as
	fully, to all intents and purposes, as the undersigned might or could do in
	person, hereby ratifying and confirming all that the Attorney-in-Fact, or
	his or her substitute or substitutes, shall lawfully do or cause to be done
	by authority of this Limited Power of Attorney.

	This Limited Power of Attorney shall remain in full force and effect until
	the undersigned is no longer required to file Forms 3, 4 or 5 with respect
	to the undersigneds holdings of and transactions in equity securities of
	the Company, unless earlier revoked by the undersigned in a signed writing
	delivered to the Attorney-in-Fact.

	This Limited Power of Attorney shall be governed and construed in
	accordance the laws of the State of California without regard to the laws
	that might otherwise govern under applicable principles of conflicts of
	laws thereof.

	IN WITNESS WHEREOF, the undersigned has caused this Limited Power of
	Attorney to be executed as of September 18, 2013.

Signature: 		/s/ Nancy T. Chang

Print Name:	Nancy T. Chang